Can an algorithm beat a fund manager? A study of quantitative vs. human-managed mutual funds finds no clear winner—but offers ...

Learn how to answer clients’ “obvious” financial questions with clarity, patience, and insight—turning confusion into trust ...

Nvidia’s market cap crossed the $1 trillion threshold in May 2023, and the $3 trillion threshold a little more than a year ...

Thursday's decision to keep the benchmark seven-day repurchase rate at 2.50% suggests that the BOK is becoming more cautious about lowering borrowing costs too aggressively amid rising household debt ...

In the near term, Southern's four natural gas distribution utilities are positioned to grow in line with Southern's electric utilities. We forecast $5.5 billion of investment at the gas utilities in ...

President Donald Trump mentioned Tuesday - almost in passing - that he planned to impose a 50% tariff on copper imports. The remark hit like a bombshell and has the potential to shake up U.S. efforts ...

Prices of Treasury debt have settled lower each trading day in July, marking the longest streak of rising yields since mid May, according to the Dow Jones Market Data team. The second-quarter vacancy ...

According to the analysts, Microsoft's AI business is experiencing "sustaining robust growth" that isn't fully reflected in the stock price. Also not reflected is the potential for Microsoft's Azure ...

Yaccarino's departure caps a tumultuous run atop Elon Musk's social-media platform and ​comes after the merger of xAI with X. Aiming for a $75 million initial fund closing, the new venture investor ...

Thursday's decision to keep the benchmark seven-day repurchase rate at 2.50% suggests the BOK is becoming more cautious about lowering borrowing costs too aggressively amid rising household debt and a ...

The major indexes are back near records, despite new tariff threats. Prices of Treasury debt have settled lower each trading day in July, marking the longest streak of rising yields since mid May, ...

The move bolsters Merck's lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda. The chip maker at the beating heart of the AI boom is embedded in gaming, ...